CAUSALab Clinics
CAUSALab Clinics – what is it?
CAUSALab Clinics is a free causal inference consulting service offered to early-career investigators in the Boston area who conduct research on comparative effectiveness or safety of health interventions.
Investigators will present work in progress, and CAUSALab postdoctoral fellows will offer guidance & expertise with respect to:
- Study design (e.g., formulating a well-defined causal question, specifying the target trial)
- Data analysis (e.g., emulating the target trial, using g-methods)
- Interpretation of results
Format
One presenter will be invited for each session. We recommend that presenters prepare a 15-minute presentation (including an outline of the target trial that corresponds to the proposed research) with the remaining time allocated for questions and discussion.
If selected, presenters are expected to be prepared with data, prior analyses, or any other relevant materials (ie. supplemental slides).
When and where?
Clinics are scheduled from 1:00 – 2:00 PM ET on select Wednesdays at the Harvard T.H. Chan School of Public Health. Spring 2025, CAUSALab clinics will take place on the following days:
- January 29, 2025
- February 26, 2025
- March 19, 2025
- April 30, 2025
How to apply:
Applicants should complete the CAUSALab Clinics application form. Applications are reviewed on a rolling basis. If selected, you will be contacted via email to coordinate a presentation date.
Questions? Please contact Emma McGee (emcgee@hsph.harvard.edu) and Daniela van Santen (dkvansanten@hsph.harvard.edu).
Past presentation topics:
- Comparative effectiveness and safety of different cardiovascular interventions
- Colchicine for limb preservation in peripheral artery disease
- Impact of Medicare’s transitional care management program on clinical outcomes of patients after discharge home from the hospital
- Challenges in estimating the comparative effectiveness of EEG-guided anti-seizure treatment in acute brain injury
- Individualizing estimates of benefit and harm for older adults considering anticoagulants for atrial fibrillation
- Utilizing instrumental variable approaches in evaluating the effectiveness of monoclonal antibodies in the treatment of asthma